Jennifer Jarrett Returns to Arcus Biosciences as Chief Operating Officer

Business Wire

Published

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that Jennifer Jarrett has rejoined Arcus as Chief Operating Officer with responsibility for Arcus’s commercial and general & administrative organizations, including finance and human resources. Ms. Jarrett is an accomplished executive in the healthcare and technology industries. She has a consistent track recor

Full Article